Skip to content
  • Health Library
  • Find a Doctor
  • Refer a Patient
  • News
  • Careers

Consult QD - A site for physicians and healthcare professionals from Cleveland Clinic. Discover the latest research insights, innovations, treatment trends and more.

Search
Primary Menu ☰
  • Specialties
    • Behavioral Health
    • Cancer
    • Dermatology & Plastic Surgery
    • Diabetes & Endocrinology
    • Digestive
    • Geriatrics
    • Heart, Vascular & Thoracic
    • Neurosciences
    • Nursing
    • Ob/Gyn & Women’s Health
    • Ophthalmology
    • Orthopaedics
    • Otolaryngology & Dentistry
    • Pain Management
    • Pathology
    • Pediatrics
    • Primary Care
    • Pulmonary & Critical Care
    • Rheumatology & Immunology
    • Urology & Nephrology
  • Peer-to-Peer Insights
    • Basic & Translational Science
    • Bioethics
    • COVID-19
    • Functional Medicine
    • Genomic Medicine
    • Global Medicine
    • Health Information Technology
    • Leadership
    • Professional staff at Consult QD
    • Transplant
  • Resources
    • Cleveland Clinic Alumni
    • Cleveland Clinic Caregiver Office
    • Cleveland Clinic Florida
    • Cleveland Clinic Journal of Medicine
    • Cleveland Clinic London
    • CME
    • Consult QD Live
    • Institutes & Services
    • Outcomes
    • Resources For Medical Professionals

Research

May. 25, 2021 / Pathology / Research

Characterizing Patient Immune Responses to Emerging Tick-borne Virus

Cleveland Clinic researchers have performed the first comprehensive immunoprofiling study of patients with severe fever with thrombocytopenia syndrome (SFTS), an emerging tick-borne disease.

Read More
Characterizing Patient Immune Responses to Emerging Tick-borne Virus
Mar. 19, 2018 / Pathology / Research

A New Marker for Neuroendocrine Lung Tumors: INSM1

A study presented at the USCAP 2018 Annual Meeting finds that insulinoma-associated protein 1 (INSM1) is a reliable marker for the diagnosis of neuroendocrine lung tumors, including small-cell lung carcinoma.

Mar. 19, 2018 / Pathology / Research

New AJCC TNM Edition More Accurately Predicts Recurrence in Pulmonary Carcinoid Tumors

A single-institution study presented at the USCAP 2018 Annual Meeting finds that the 8th edition of the American Joint Committee on Cancer Staging Manual predicts recurrence in pulmonary carcinoid tumors more accurately than its predecessor.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

ConsultQD

A site for physicians and healthcare professionals. Discover Cleveland Clinic’s latest research insights, innovations, treatment trends and more.

Advertising Policy
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • LinkedIn
  • Pinterest
  • Snapchat

Cleveland Clinic

  • Home
  • About Cleveland Clinic
  • Careers at Cleveland Clinic
  • Giving
  • Office of Diversity & Inclusion
  • Community Outreach
  • Research & Innovations
  • Health Library
  • Free Health eNewsletters
  • Resources for Medical Professionals
  • Media Relations

Social Media & Mobile Apps

  • Send Us Feedback
  • About this Website
  • Advertising Policy
  • Social Media Policy
  • Copyright, Reprints & Licensing
  • Website Terms of Use
  • Website Privacy Policy
  • Notice of Privacy Practices
  • Non-Discrimination Notice

Resources

  • Mobile Apps
  • Podcasts
Cleveland Clinic © 1995-2023. All Rights Reserved. 9500 Euclid Avenue , Cleveland , Ohio 44195 | 800.223.2273 | TTY 216.444.0261